Key result
Pacemaker malfunction occurred in 50% (2 of 4) of patients with localized prostate cancer undergoing passive proton beam therapy, despite the treatment isocenter being >50 cm away from the device.
Why the study?
Does passive proton beam therapy cause pacemaker malfunction in patients with localized prostate cancer?
Case Report (n=4)
No
Does passive proton beam therapy cause pacemaker malfunction in patients with localized prostate cancer?
Passive proton beam therapy for localized prostate cancer can cause pacemaker malfunction due to secondary neutrons, even when the treatment isocenter is >50 cm away from the device.
Answers are grounded in this paper and cite their sources.
May warrant CIED monitoring during passive proton therapy; hypothesis-generating in small case series and requires prospective confirmation.
We report two cases of pacemaker malfunction occurring during proton beam therapy (PBT) for localized prostate cancer treatment. The first case involved mode changes in the pacemaker, while the second exhibited prolongation of the RR interval. Remarkably, both cases did not manifest significant clinical changes. Our findings indicate that careful consideration should be given to passive PBT in patients with localized prostate cancer who have pacemakers, like the considerations in patients with thoracic and abdominal cancers. Moreover, our report highlights the importance of recognizing potential cardiac implantable electronic devices malfunction in various PBT scenarios.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2023) conducted a case report in Localized prostate cancer with implanted pacemakers (n=4). Passive proton beam therapy was evaluated on Pacemaker malfunction during proton beam therapy. Pacemaker malfunction occurred in 50% (2 of 4) of patients with localized prostate cancer undergoing passive proton beam therapy, despite the treatment isocenter being >50 cm away from the device.
Synapse has enriched 10 related papers. Consider them for comparative context: